Evaluation of the Antihypertensive Properties of Curcuma Longa (Turmeric)
International Journal of Creative and Open Research in Engineering and Management · 27.05.2026 · 02 (05) · 1-21
DOI: 10.55041/ijcope.v2i5.757 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Creative and Open Research in Engineering and Management, online erschienen am 27.05.2026. Verfasst von shankul kumar shankul kumar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Elevated arterial blood pressure stands among the foremost contributors to global cardiovascular morbidity, affecting well over one billion adults worldwide. Pharmacological management, while effective, is accompanied by tolerability issues that frequently undermine long-term patient adherence. Against this backdrop, Curcuma longa L. — the rhizomatous spice plant widely known as turmeric — has attracted sustained scientific inquiry owing to its rich curcuminoid content and its centuries-long role in South and Southeast Asian healing traditions. This review consolidates findings from in vitro investigations, controlled animal experiments, and published human trials to construct a coherent picture of how turmeric-derived constituents, particularly curcumin, may favourably modulate blood pressure. The mechanistic canvas is broad: curcumin stimulates endothelial nitric oxide synthase (eNOS), competitively inhibits angiotensin-converting enzyme (ACE), suppresses nuclear factor kappa-B (NF-κB)-driven vascular inflammation, activates the Nrf2 antioxidant axis, antagonises voltage-gated calcium channels in vascular smooth muscle, and attenuates multiple steps within the renin-angiotensin-aldosterone cascade. Clinical meta-analyses report modest yet meaningful reductions in systolic and diastolic pressure, with more pronounced effects in individuals carrying concurrent metabolic burdens. Oral bioavailability of native curcumin remains the central translational obstacle, though phospholipid, nanoparticulate, and micellar delivery platforms have substantially narrowed this gap. We conclude that curcumin warrants further evaluation as a safe adjunctive option in cardiovascular risk management, contingent on rigorously designed, large-scale randomised trials. Keywords: Curcuma longa; curcumin; hypertension; antihypertensive; nitric oxide; renin- angiotensin system; oxidative stress; vascular pharmacology; herbal medicine
Zitieren
APA
kumar, S. K. S., & Raj, S. R. S. (2026). Evaluation of the Antihypertensive Properties of Curcuma Longa (Turmeric). International Journal of Creative and Open Research in Engineering and Management, 02(05), 1-21. https://doi.org/10.55041/ijcope.v2i5.757
Vancouver
kumar SKS, Raj SRS. Evaluation of the Antihypertensive Properties of Curcuma Longa (Turmeric). International Journal of Creative and Open Research in Engineering and Management. 2026;02(05):1-21. doi:10.55041/ijcope.v2i5.757
BibTeX
@article{kumar2026,
author = {kumar, shankul kumar shankul and Raj, Supriya Raj Supriya},
title = {Evaluation of the Antihypertensive Properties of Curcuma Longa (Turmeric)},
journal = {International Journal of Creative and Open Research in Engineering and Management},
year = {2026},
volume = {02},
number = {05},
pages = {1--21},
doi = {10.55041/ijcope.v2i5.757}
}
EUVIMED